Method for treatment of obesity using prolactin modulators and diet
US5744477A · kind A · utility
Assignees
Inventors
Key dates
| Filing date | Jan 7, 1994 |
| Grant date | Apr 28, 1998 |
| Priority date | — |
| Expiry date | Jan 7, 2014 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/74
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to an improvement in a method of weight and/or body-fat reduction comprising a (preferably moderate) reduction in the caloric intake of a subject in need of such treatment in combination with administration to said subject of a prolactin inhibitor. Additionally, the present invention is directed to an improvement in a method for altering and/or resetting prolactin profiles (and thereby controlling one or more metabolic disorders such as obesity, excessive body fat, hyperlipidemia, hyperlipoproteinemia, hyperglycemia, hypercholesterolemia, hyperinsulinemia, insulin resistance, glucose intolerance, and Type II diabetes) comprising administration to a subject in need of such treatment of a prolactin inhibitor at a predetermined time or times during a 24-hour period in combination with a (preferably moderate) reduction of the caloric intake of said subject.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.